Genome-wide linkage scan for loci associated with epilepsy in Belgian shepherd dogs. by Oberbauer, Anita M et al.
UC Davis
UC Davis Previously Published Works
Title


















eScholarship.org Powered by the California Digital Library
University of California
Oberbauer et al. BMC Genetics 2010, 11:35
http://www.biomedcentral.com/1471-2156/11/35
Open AccessR E S E A R C H  A R T I C L EResearch articleGenome-wide linkage scan for loci associated with 
epilepsy in Belgian shepherd dogs
Anita M Oberbauer*, Janelle M Belanger, Deborah I Grossman, Kelly R Regan and Thomas R Famula
Abstract
Background: Idiopathic epilepsy in the Belgian shepherd dog is known to have a substantial genetic component. The 
objective of this study was to identify genomic regions associated with the expression of generalized seizures in the 
Belgian Tervuren and Sheepdog.
Results: DNA from 366 dogs, of which 74 were classified as epileptic, representing two extended families were 
subjected to a genome-wide linkage scan using 410 microsatellite markers yielding informative coverage averaging 
5.95 ± 0.21 Mb. Though previous studies based on pedigree analyses proposed a major gene of influence, the present 
study demonstrated the trait to be highly polygenic. Studies of complex disorders in humans indicate that a liberal 
composite evaluation of genetic linkage is needed to identify underlying quantitative trait loci (QTLs). Four 
chromosomes yielded tentative linkage based upon LOD scores in excess of 1.0. Possible QTLs within these regions 
were supported also by analyses of multipoint linkage, allele frequency, TDT, and transmission of haplotype blocks.
Conclusions: Taken together the data tentatively indicate six QTLs, three on CFA 2, and one on each of CFA 6, 12, and 
37, that support fine mapping for mutations associated with epilepsy in the Belgian shepherd. The study also 
underscores the complexity of genomic linkage studies for polygenic disorders.
Background
Belgian Tervuren (BT) and Belgian Sheepdogs (BS) (col-
lectively referred to as Belgian shepherd dogs outside of
the United States) have a long history of idiopathic epi-
lepsy [1,2]. An early study found the prevalence of epi-
lepsy for BT in the United States to be 17% [3] which is
higher than the estimated prevalence of 9.5 - 11.1% for
BT and BS in Denmark [2]. In the general dog population,
the prevalence of epilepsy is estimated to be approxi-
mately 1.0% [4]. Regardless of the precise prevalence of
idiopathic epilepsy, the prevalence in the Belgian shep-
herd is perceived to be too great and efforts to reduce the
incidence are desirable.
As in other breeds [5-8], the presumed mode of inheri-
tance for idiopathic epilepsy in the Belgian shepherd is
polygenic with a recessive gene of major influence [3,9].
In addition to a genetic component, other factors are
believed to contribute to the expression of epilepsy, possi-
bly by lowering the seizure threshold; these factors
include stress [2,10] and sex steroids [2]. In general, sei-
zure activity in the Belgian shepherd begins about 4 years
of age [2,3] and treatment varies from none, to anticon-
vulsive medication (phenobarbital and/or potassium bro-
mide), to euthanasia for intractable cases.
Due to the similarities of seizure activity between
humans and dogs [11], the use of the human Interna-
tional League Against Epilepsy (ILAE) scheme [12] has
been proposed for the classification of seizures for dogs
to improve consistency in data recording [2,11]. Using the
ILAE system, Berendt [2] completed a comprehensive
survey of epilepsy in the Belgian shepherds of Denmark
and reported the prevalence of epilepsy at 9.5% (49 out of
516 dogs). Of these 49 epileptic dogs, 71% of the dogs
experienced either primary or secondarily generalized
seizures.
Identification of a locus linked to the expression of epi-
lepsy would assist in reducing the prevalence of idio-
pathic epilepsy in the Belgian shepherd and may also
provide clues to mutations contributing to epilepsy in
other breeds. Genetic testing currently is used by dog
breeders seeking to improve the health of their breeds as
evidenced by participation in the Canine Health Informa-
tion Center [13] while compulsory implementation of
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considered in the United Kingdom [14]. Further, the sim-
ilarities of seizure disorders between humans and dogs
[15] suggest that the findings of one species can aid the
progress in the other. With that objective, a genome-wide




Dog owners who participated in the study were recruited
with cooperation from the American Belgian Tervuren
Club, the Belgian Sheepdog Club of America, interested
breeders, and individual owners. Research protocols were
approved by the Institutional Animal Care and Use Com-
mittee of University of California, Davis. The present
study included purebred Belgian Tervuren (BT) and Bel-
gian Sheepdogs (BS) affected with epilepsy, as well as
unaffected dogs. Genomic DNA was obtained by owners
submitting three buccal swabs from each dog. Along with
the DNA sample, owners provided specific seizure infor-
mation (frequency, onset and duration of seizures), veter-
inary reports, and a three-generation pedigree. The dogs
were designated as phenotypically epileptic based on
information provided by the owner and veterinarian.
Dogs were defined as epileptic if they exhibited repeated
"epileptic seizure phenomenology" common to general-
ized seizures based upon the classification system used
for humans and applied in dogs [2].
The BT data set consisted of 355 dogs, including 177
dogs for which buccal swab derived DNA was available
for analysis and 178 additional dogs included to construct
the appropriate pedigrees for analysis (Additional File 1).
Of the dogs for which DNA was available, 134 were desig-
nated as unaffected, 36 designated as having affected epi-
lepsy status, and 7 having indeterminate ("unknown")
status. The dogs without DNA submitted and included to
complete the pedigrees were largely designated as
"unknown" for the status except for deceased dogs known
to meet the epileptic designation criteria (five dogs).
Dogs classified as epileptic were equally represented by
males and females (18 and 18, respectively; p > 0.5). For
the dogs classified as epileptic, the average age at first
observed seizure was 47.5 months, an age comparable to
previously published data [2,3]. Dogs were designated as
"unaffected" if they had no reported seizure activity and
were over 6 years of age; six years of age was selected
because nearly 90% of BT and BS dogs defined as epilep-
tic were under the age of 6 years at age at first recorded
seizure (Additional File 2).
The BS breed, which is highly related to the BT [16],
was used to independently assess the findings of the BT
association. The BS data set also consisted of 355 dogs,
including 189 dogs for which buccal swab derived DNA
was available for analysis and 166 additional dogs (again
included to construct the appropriate pedigrees for anal-
ysis with epilepsy status classified as unknown). Of the
dogs for which DNA was available, 147 were designated
as unaffected, 38 designated as having affected epilepsy
status, and 4 were classified as unknown. Similar to the
BT male and female distribution, epileptic BS dogs were
equally distributed between the two sexes (p > 0.5). The
average age at seizure onset in the BS dogs was 45.5
months.
DNA collection, microsatellite markers and PCR methods
Genomic DNA was extracted from the buccal swabs [17]
and used in a whole genome-wide linkage study. An ini-
tial genome scan of 100 microsatellite markers was run
on a modest number of BT [9] and expanded in the pres-
ent study for a total of 436 microsatellite markers. Mark-
ers were selected from various sources, including the
1999 canine genetic linkage map [18], Minimal Screening
Set 2 [19] and the University of California, Davis linkage
map [20]. Criteria used in marker selection were to pro-
vide 9-Mb coverage of the canine genome and the ability
to be amplified by PCR in multiplex reactions. Microsat-
ellite markers were amplified and resolved in multiplexed
sets using standard procedures [21]. A high-throughput
scanning fluorescence detector system was used to
resolve the labeled PCR products (Applied Biosystems,
Life Technologies, Carlsbad, CA) and genotypes were
captured by STRand genotyping software v2.3.106
(STRand, Davis, CA available at http://www.vgl.ucda-
vis.edu/STRand) [22].
Statistical analyses
Several linkage analyses were undertaken; the first mak-
ing use of the variance components strategy introduced
by Almasy and Blangero [23]. Two-point and multipoint
linkage analyses were performed using the SOLAR soft-
ware package v4.2.0. Two phenotypes were considered in
these analyses, one the binary trait of epilepsy (using a
liability threshold model as outlined in Duggirala et al.
[24], the second trait was age at onset for this seizure dis-
order. Age at onset was evaluated as a continuous vari-
able, taken as the Martingale residual from the Cox
proportional hazards model fit on age of first seizure,
accommodating censoring, as suggested by Yoo et al. [25].
The proportional hazards model took the following alge-
braic form
where yij is the observed age at first seizure (including
accommodation for censoring in those animals that are
free of disease), μ is an unknown constant, sex is the
y sex eij i ij= μ + + (1)
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ual. Computation of the Cox proportional hazards model
and the ensuing Martingale residuals was facilitated
through the survival package of the public domain lan-
guage R (version 2.9.1) [26].
Epilepsy was evaluated with or without correction for
age at onset as well as sex of dog. Algebraically, this yields
a model of
where yij is the observed epilepsy phenotype (yes/no), μ
is an unknown constant, sexi is the effect of the i-th sex (i
= 1,2), β is the regression coefficient for age at first sei-
zure and eij is an unknown residual. When age at onset
was evaluated as a dependent variable, the effect of the
sex of dog was included as an independent variable. For
either phenotype, a two-point analysis was done, moving
to the multipoint analysis for chromosomes suggested to
play an important role in the expression of phenotype.
An additional two-point linkage analysis was under-
taken with CRI-MAP v2.4 according to published
instructions [27]. Application of this technique requires
an assumption about the potential for a single locus con-
tribution to the expression of epilepsy, along with a sug-
gested mode of inheritance (i.e., recessivity/dominance).
Though previous analyses of pedigrees suggested a major
locus of large effect impacting epilepsy in the Belgian
shepherd dog [9], the variance component strategy of
Almasy and Blangero [23] does not require assumptions
on the mode of inheritance and genetic parameters for
putative QTLs.
For the chromosomes of interest, the simple technique,
sib-pair analysis, proposed some time ago by Haseman
and Elston [28] was used. The technique regresses the
square of phenotypic differences between sibs on the
identity by descent values for marker genotypes in the
two sibs [29]. The identity by descent values were those
computed with SOLAR v4.2.0, and regressions computed
with the public domain language R [26].
Relationships between disease status and the presence
or absence of various marker alleles (or allelic combina-
tions) were evaluated by the Fisher exact test using pub-
lished criteria for linkage between the marker and a
genetic locus for epilepsy [30] though this test is more
suited for random samples than samples including famil-
ial relationships. Sensitivity and specificity analyses were
performed to assess the diagnostic value of the presence/
absence of disease with a given genotypic classification
[31].
Haplotypes were generated with Mendel 8.0 (Haplo-
type option 3) [32]. The magnitude of the pedigree
required the BT and BS families to be split into smaller
family structures composed of 20-50 dogs focused
around founding sires with affected and unaffected off-
spring. Affected dogs and their parents were analyzed by
the transmission/disequilibrium test (TDT) using Men-
del 8.0 (TDT Analysis Option 13) [32]. The TDT analysis
assigns P-values by using a permutation procedure that
shuffles alleles as passed or not passed to each offspring
from its parents. Within the dataset there were three dogs
in which both parents were genotyped, 18 dogs with one
parent genotyped and one parent lacking genotypic infor-
mation, and 14 dogs for which both parents had
unknown genotype. For parental dogs in which DNA and
genotypes were not available, haplotype alleles were
assigned by the MENDEL haplotype option by using the
genotypes of offspring or, if only a single offspring, the
allele frequencies within the family with the highest fre-
quency allele assigned. Haplotype blocks composed of
four markers surrounding markers with suggestive two-
point linkage LOD scores were determined. After identi-
fying each unique haplotype, haplotype frequencies
within a block for each phenotype were compared by χ2
statistics. Though multiple comparisons were made, and
the results need caution in interpretation, assessing hap-
lotype frequencies were merely one in a number of link-
age assessments. Further, following the recommendations
of Rothman, as well as Perneger [33,34], adjustments for
multiple comparisons were not performed.
Results
Genome-wide markers
Of the 436 microsatellite markers used, 410 consistently
amplified the genomic DNA (Additional File 3) and had
verifiable chromosomal positions on the complete canine
genome map [35,36]. Of those, 353 yielded PIC values
equal to or in excess of 0.30 in the two breeds (informa-
tive markers) with a high of 0.9 (representing 16 distinct
alleles); the mean and median PIC value was 0.58 for
markers with PIC values ≥ 0.3 or above. An additional 37
markers gave PIC values between 0.10 and 0.30. The
informative markers provided an average coverage of 5.95
± 0.21 Mb and a median coverage of 5.41; the largest
block without a PIC > 0.3 marker coverage was 32.36 (one
block) and 11 regions >15 Mb (including the 32.36 block).
Linkage between the informative markers was validated
using the two-point option in CRI-MAP.
The BT and BS pedigrees used in the present study
were modeled empirically to assess if they had the power
to generate chromosome-wide significant linkage
between the epileptic phenotype and the markers used.
Using simulated marker genotypes, the simulations dem-
onstrated that the families composed provided sufficient
power to detect linkage with the SOLAR analyses. LOD
scores in excess of 12.0 were possible for these pedigrees
y sex (age at first seizure) eij i ij ij= + +μ +b (2)
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an autosomal recessive with a single gene of major influ-
ence as previously predicted [3]. However, the complexity
of the expression and characterization of the disorder
along with the polygenic nature, would suggest LOD
scores of lower magnitude to be expected.
Linkage
Applying standards used in genome-wide linkage studies
of human polygenic disorders [37-39], SOLAR LOD
scores in excess of 1.0 were considered suggestive of link-
age. Four different chromosomes had regions that met
the LOD threshold criterion. Table 1 presents the two-
point LOD scores from the binary trait of epilepsy and
the continuous trait of age at onset analyses. The LOD
scores generated from the multipoint analyses for the
binary trait of epilepsy are presented as the highest multi-
point LOD score nearest the associated marker. The
dichotomous nature of the age at onset observed in the
present data suggests that adjustment for age at onset was
not necessary, a finding supported by the marginal
improvement in two-point LOD scores when age at onset
was evaluated. The tentative QTLs were located on chro-
mosomes CFA 2, 6, 12, and 37. For all markers examined
the strongest two-point BT LOD scores for the binary
trait of epilepsy were found on CFA 12: 1.221 and 1.212
for FH3591 and FH2054, respectively. SOLAR LOD
scores for the BS supported the findings in the BT. For the
BS dogs, the strongest BS LOD scores for all markers
examined were found on CFA 37: 1.382 and 1.159, for
AHT133 and REN67C18 respectively; these markers cor-
responded to the same region as the highest BT CFA 37
multipoint LOD score. Significance for the BT and BS
dogs was also detected for these four chromosomal
regions by the Fisher exact test (Table 1).
To corroborate those findings, additional tests of link-
age were performed (Table 1) including a second linkage
analytical program (CRI-MAP) and sib-pair analysis.
Allelic transmission was evaluated by the TDT test and
assessing haplotype blocks. Only two CRI-MAP LOD
scores exceeded 1.0: at the marker located approximately
at 81.01 Mb on CFA 2 and at 55.33 Mb on CFA 12. The
CRI-MAP suggestive linkage on CFA 2 was within the
region identified by the two-point analyses whereas the
CFA 12 suggestive linkage was adjacent to the region
identified. Sib-pair analyses were only significant for CFA
12 (in a region adjacent to, but not within, the region
identified by the two-point) and CFA 37 in the BT. For
the BS, only CFA 9 had significant sib-pair linkage; CFA 9
did have suggestive linkage in both the BT and BS based
on the Fisher and TDT assessments but the LOD score
was not supportive. The TDT and haplotype block tests
agreed with the association identified by the two-point
linkage analyses. For the BT dogs, CFA 2, 6, 12, and 37
showed specific alleles (p < 0.05) being passed more to
affected dogs than to unaffected dogs suggesting that the
markers on these chromosomes are disease-predisposing
or closely linked to such a locus.
Taken together, there were six genomic regions exhibit-
ing tentative QTLs for the epileptic phenotype; one chro-
mosome, CFA 2, had more than one region associated.
The approximate locations of QTLs were CFA 2 at 7.16-
15.50 Mb, 43.23 - 46.62 Mb, and 69.34 - 81.01 Mb; CFA 6
at 15.58-30.97 Mb; CFA 12 at 24.28 - 44.55 Mb; and CFA
37 at 18.09 - 22.39 Mb.
Discussion
The aim of this work was to detect microsatellite markers
associated with the epileptic phenotype in the Belgian
shepherd. Using multiple assessments, we sought congru-
ence of the results to identify linkage to specific genomic
regions. Given that the disorder is complex in expression
and in inheritance, LOD scores achieving classical signifi-
cance in excess of 3.0 were not achieved. Lower LOD
scores that are viewed as suggestive of linkage are fre-
quently used in genome linkage studies for human poly-
genic traits and disorders [37-39] as well as complex
disease in horses [40]. The complex nature of epilepsy in
the dog would also suggest a liberal interpretation of
potential linkage indicators is appropriate. By applying
numerous assessments to confirm suggestive LOD
scores, the likelihood of identifying false linkage was
reduced.
Within the population studied, males and females were
equally affected and the age at onset was, for the vast
majority of dogs, prior to 6 years of age. Dogs in which
the first seizure was reported at older ages may reflect a
different form of epilepsy representing different muta-
tions, or quite possibly earlier seizure episodes that went
unnoticed by owners. The dataset demonstrated that
although the risk of expressing epilepsy changes with age,
the risk of expressing epilepsy drops precipitously with
increasing age. Specifically, epilepsy, like many disorders
would be expected to have a significant age at onset com-
ponent. Any linkage analysis should therefore accommo-
date this anticipated effect. Yet as the counts in the
supplemental table reveal, there was a dichotomous
nature to age at onset in the present data suggesting age
at onset was accounted for by the trait of epilepsy. Indeed,
the polyserial correlation of age of observation and epi-
lepsy status was -1.0 (computed with package polycor in
R) [26]. The linkage analysis for age of onset measured as
the Martingale residual yielded results nearly identical to
the binary trait of epilepsy without any age adjustment, as
should be expected if age of observation and epilepsy sta-
tus were so closely related.
In some cases single LOD scores were potentially inter-
esting but unsupported by adjacent markers, multipoint,
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linkage and association, six genomic regions on four
chromosomes were found to tentatively harbor QTL
associated with epilepsy in the Belgian shepherd. The
linkage blocks, although large, perhaps represent the best
available evaluation using a linkage association based on
microsatellites and their incumbent limitations. For
example, 13% of the microsatellites specifically chosen for
their allele diversity were uninformative for use in the BT
and BS populations. In contrast, microsatellites seem to
be very useful in the exclusion of potential candidate
genes [41]. If applied to the present study, numerous
chromosomes can be excluded from further consider-
ation as harboring major QTL associated with epilepsy.
The rather limited utility of the sib-pair analysis was
not unexpected given the design of the experiment as a
familial linkage study and the incomplete availability of
littermates from a given breeding. However, all the data
taken together do provide compelling evidence of sugges-
tive QTLs in influencing the expression of epilepsy in the
Belgian shepherd dog. From the present study microsat-
ellites appear to lack resolution to clearly identify possible
causal mutations for a complex, variable phenotypic dis-
order. Fine mapping of these regions will require greater
saturation of markers to generate greater haplotype diver-
sity using the genetic structure of the dog [42].
There are numerous positional candidate genes, based
upon their involvement in human epilepsy, possible for
these six regions. Syntenic to CFA 2 are the human genes
BAFME2 (Benign adult familial myoclonic epilepsy 2)
[43] and EIG5 (Epilepsy, idiopathic generalized, suscepti-
bility to, 5) [44]. Candidate genes on CFA 6 based on















TDT* Sib-Pair* Hap 
block*
CFA02
7.16 FH2274 0.41 0.615 0.715 0.63 0.0018 0.02 0.002 0.175
10.35 v170 0.57 0.396 0.781 0.785 0.0001 0 0.000 0.333 0.04
15.5 v163 0.55 1.095 1.616 0.802 0.0005 0 0.000 0.413
43.23 v200 0.65 0.037 0.129 0.074 0.0067 0 0.388 0.142
46.62 v205 0.56 1.063 1.447 0.08 0.3283 0.24 0.005 0.144
69.34 v235 0.63 0.252 0.133 0.864 0.0104 0.24 0.002 0.56
73.02 v240 0.69 1.001 1.415 0.834 0.0076 0.84 0.001 0.097 0.05
78.35 AHT111 0.59 0.01 0.068 0.733 0.0003 0.38 0.009 0.542
81.01 FH3965 0.78 0.15 0.031 0.735 0.7088 1.13 0.363 0.102
CFA06
15.58 v620 0.41 1.057 1.024 0.236 0.6055 0.15 0.786 0.12 0.008
26.16 v633 0.34 0.251 0.362 0.015 0.6572 0 0.876 0.447
30.97 v639 0.70 0.073 0.161 0.004 0.0283 0.02 0.000 0.454
CFA12
24.28 1-21-3 0.68 0.719 0.79 0.625 0.114 0.31 0.000 0.999
24.28 FH2054 0.67 1.212 1.26 0.634 0.5973 0.83 0.010 0.464
27.72 FH2401 0.61 0.15 0.448 0.688 0.667 0 0.094 0.844
35.37 v1172 0.39 0 0.077 0.751 0.6036 0 0.010 0.905
44.55 FH3591 0.85 1.221 1.369 0.788 0.3102 0.2 0.002 0.929 0.035
CFA37
18.09 AHT133 0.53 0.048 0.066 0.217 0.0021 0 0.013 0.288 0.003
22.39 Ren67c18 0.59 0.391 0.528 0.960 0.007 0 0.016 0.025
a Two-point LOD scores for the binary trait of epilepsy
b Two-point LOD scores for the continuous trait of age at onset
c Highest multipoint LOD score for the binary trait of epilepsy nearest the associated marker
*P-values
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associated with progressive myoclonic epilepsy [45] and
EIM [46]. There are 51 identified genes or regions associ-
ated with human epilepsy on human chromosome 6
which represents a great deal of synteny with CFA 12;
many of these genes/regions are syntenic to the QTL sug-
gested in the present study. A recent characterization of
CLN8, a gene involved in human progressive epilepsy and
found on CFA 37, was found to be mutated in English
Setter dogs having heritable neurodegenerative disease
[47]. While CLN8 is not a good candidate gene for the
phenotype of the idiopathic epilepsy seen in the Belgian
breeds, it does underscore the generalizability of the
human and canine gene discovery as it relates to epilepsy.
However, the plethora of epilepsy associated genes identi-
fied in human families, indicates that caution needs to be
applied when investigating candidate genes and that a
more precise localization would be a more prudent
approach for polygenic disorders.
The absence of robust association may be due to the
polygenic nature of the disease as noted before. Further
aspects that confound the study of epilepsy are the accu-
racy of seizure characterization, the subtle differences in
seizure presentation that while appearing to be common
in terms of expression represent differences in underlying
genetic causality, and the classification as idiopathic epi-
lepsy in the absence of a positive diagnosis. Recent
reports of canine epilepsy suggest that the genetics
involved in seizures may be distinctly different within the
different lines of a single breed [11]. Additionally, some
disorders described as polygenic are the result of copy
number variations [48] and the approach of linkage map-
ping used in the present study would not identify copy
number variability. Another consideration in complex
diseases is the concept of "common disease/common
variant" hypothesis whereby it is assumed that a common
complex disease is caused by few but common genetic
variants. However, it is also likely that a particular combi-
nation of relatively rare alleles could also evoke the dis-
ease [49]. If the latter is the case for canine epilepsy then
the classical linkage studies may be insufficient to detect
the genomic regions.
Conclusion
The composite data presented here suggests six chromo-
somal regions on four chromosomes may tentatively har-
bor QTLs involved in generalized idiopathic epilepsy in
the Belgian shepherd dog. Fine mapping is necessary
using single nucleotide polymorphisms which should
enable the identification of genes and mutations in pre-
disposing a dog to seizure activity.
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